Interleukin-17 in post-stroke neurodegeneration

@article{Swardfager2013Interleukin17IP,
  title={Interleukin-17 in post-stroke neurodegeneration},
  author={W. Swardfager and D. Winer and N. Herrmann and S. Winer and K. Lanct{\^o}t},
  journal={Neuroscience \& Biobehavioral Reviews},
  year={2013},
  volume={37},
  pages={436-447}
}
Stroke is a leading cause of physical disability with neurodegenerative sequelae such as dementia and depression causing significant excess morbidity. Stroke severity can be exacerbated by apoptotic cell death in ischemic tissue, of which inflammatory activity is a key determinant. Studies have identified harmful and beneficial sets of T lymphocytes that infiltrate the brain post-stroke and their activation signals, suggesting that they might be targeted for therapeutic benefit. Animal models… Expand
Interleukin‐17 and ischaemic stroke
TLDR
This review focuses on the pathological modulation and the mechanism of IL‐17 family in ischaemic stroke and seeking to provide new insights for future therapies. Expand
Roles of Pro- and Anti-inflammatory Cytokines in Traumatic Brain Injury and Acute Ischemic Stroke
This chapter will introduce the reader to the pathophysiology of two devastating neurologic events, traumatic brain injury (TBI) and acute ischemic stroke (AIS). Here we focus on the role of keyExpand
AIM2 inflammasome contributes to brain injury and chronic post-stroke cognitive impairment in mice
TLDR
Conclusively, AIM2 inflammasome-mediated inflammation and pyroptosis likely aggravated PSCI; therefore, targeting and controlling AIM1 inflammaome could potentially treat PSCi. Expand
Poststroke Neuropsychiatric Symptoms: Relationships with IL-17 and Oxidative Stress
TLDR
Poststroke depressive symptoms may be associated with cognitive vulnerability to IL-17 related pathways, involving an imbalance between proinflammatory and anti-inflammatory activity and increased oxidative stress. Expand
PR‐957 mediates neuroprotection by inhibiting Th17 differentiation and modulating cytokine production in a mouse model of ischaemic stroke
TLDR
The neuroprotective effect of PR‐957 indicates its potential utility as anti‐inflammatory therapy for ischaemic stroke and provides neuroprotection via inhibiting T lymphocyte infiltration and decreasing T helper type 17 (Th17) cell differentiation in MCAO mice. Expand
Rational modulation of the innate immune system for neuroprotection in ischemic stroke
TLDR
Immunity cells exert a dualistic role on the evolution of ischemic brain damage, since the classic phenotypes promote injury, whereas alternatively activated M2 macrophages or N2 neutrophils prompt tissue remodeling and repair. Expand
Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
TLDR
The gut‐brain axis may serve as a contributing factor to disease pathology and offer innovative approaches in cell‐based regenerative medicine for the treatment of neurological diseases and the effects of gut microbiota on cognitive decline and brain pathology are discussed. Expand
Imbalance between IL-17A-Producing Cells and Regulatory T Cells during Ischemic Stroke
TLDR
The proportion of peripheral Tregs and the levels of IL-10 and TGF-β were reduced in patients with IS compared with controls using flow cytometry, real-time PCR, and ELISA assays, but the proportions of Th17 and γ δ T cells, the primary IL-17A-secreting cells, increased dramatically, and these effects were accompanied by increases in the levels in IS patients. Expand
Chronic exposure to IL-6 induces a desensitized phenotype of the microglia
TLDR
Evaluating the effects of chronic IL-6 production on the immune response associated with CNS-axonal anterograde degeneration found an increase in the microglia/macrophage density was observed in GFAP-IL6Tg animals in non-lesion conditions and at later time-points after PPT, associated with higher microglial proliferation and a major monocyte/macophage cell infiltration. Expand
Identification of IL-17A-derived neural cell type and dynamic changes of IL-17A in serum/CSF of mice with ischemic stroke
TLDR
Astrocytic IL-17A peaks in CSF within 12 h and in serum at 3 d reperfusion after ischemic stroke may exaggerate neuronal injuries through its receptor IL- 17R at early stage of ischeic stroke. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 150 REFERENCES
Neutralization of the IL-17 axis diminishes neutrophil invasion and protects from ischemic stroke.
TLDR
It is proposed that selective targeting of IL-17A signaling might provide a new therapeutic option for the treatment of stroke, and this aspect of the inflammatory cascade is also relevant in the human brain. Expand
[Role of T lymphocytes in ischemic brain injury].
TLDR
It is shown that IL-23 and IL-17 but not IL-6 or IFN-γ play pivotal roles in the ischemic brain injury, and administration of FTY720 (Fingolimod) and antibody against γδT lymphocytes attenuated isChemic brain damage and anti-cytokine therapy will be applicable for neuroprotection in the delayed phase of brain ischemia. Expand
Pivotal role of cerebral interleukin-17–producing γδT cells in the delayed phase of ischemic brain injury
TLDR
It is demonstrated that the infiltration of T cells into the brain, as well as the cytokines interleukin-23 (IL-23) and IL-17, have pivotal roles in the evolution of brain infarction and accompanying neurological deficits, and proposed that T lymphocytes, including γδT lymphocyte, could be a therapeutic target for mitigating the inflammatory events that amplify the initial damage in cerebral ischemia. Expand
Inflammatory Cytokines in Experimental and Human Stroke
  • K. Lambertsen, K. Biber, B. Finsen
  • Medicine
  • Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2012
TLDR
The fact that TNF and IL-1, and suppossedly also IL-6, are produced by microglia within the therapeutic window place these cells centrally in potential future stroke therapy, in the context of suggestions that neuronal sensitivity to ischemia may be modulated by cytokines. Expand
Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients
TLDR
Low levels of interleukin-10 indicate that the anti-inflammatory response is down-regulated in acute stroke patients, and a possible correlation with other hematological parameters, clinical outcome, size of infarct and subtypes of strokes is analyzed. Expand
The immunology of stroke: from mechanisms to translation
TLDR
Gaining a better understanding of the reciprocal interaction between the immune system and the ischemic brain is essential to harness the full therapeutic potential of the immunology of stroke. Expand
Post-Ischemic Inflammation in the Brain
TLDR
This review focuses on the post-ischemic inflammation triggered by infiltrating immune cells, macrophages, and T lymphocytes, which is an essential step in the progression of brain ischemia-reperfusion injury. Expand
Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
TLDR
Treg cells are major cerebroprotective modulators of postischemic inflammatory brain damage targeting multiple inflammatory pathways, and IL-10 signaling is essential for their immunomodulatory effect. Expand
Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae.
TLDR
The evidence to support the use of lithium to reduce neuronal damage post-stroke through mechanisms of excitotoxicity and post-ischemic inflammation; and 2) neurotrophic signaling cascades is reviewed. Expand
Inhibition of the Inflammasome Complex Reduces the Inflammatory Response after Thromboembolic Stroke in Mice
TLDR
Findings show that the inflammasome complex forms after focal brain ischemia and may be a novel therapeutic target for reducing the detrimental consequences of postischemic inflammation. Expand
...
1
2
3
4
5
...